Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis.
Nozawa M, Inagaki T, Nagao K, Nishioka T, Komura T, Esa A, Kitagawa M, Imanishi M, Uekado Y, Ogawa T, Kajikawa H, Uejima S, Matsuyama H, Hara I, Uemura H.
Nozawa M, et al. Among authors: uejima s.
Int J Clin Oncol. 2014 Aug;19(4):693-701. doi: 10.1007/s10147-013-0604-z. Epub 2013 Aug 3.
Int J Clin Oncol. 2014.
PMID: 23912936
Clinical Trial.